A Dipeptidyl Peptidase-4 Inhibitor Inhibits Foam Cell Formation of Macrophages in Type 1 Diabetes via Suppression of CD36 and ACAT-1 Expression

Dipeptidyl peptidase-4 (DPP-4) inhibitors have been reported to play a protective role against atherosclerosis in both animal models and patients with type 2 diabetes (T2D). However, since T2D is associated with dyslipidemia, hypertension and insulin resistance, part of which are ameliorated by DPP-...

Descripción completa

Detalles Bibliográficos
Autores principales: Terasaki, Michishige, Yashima, Hironori, Mori, Yusaku, Saito, Tomomi, Matsui, Takanori, Hiromura, Munenori, Kushima, Hideki, Osaka, Naoya, Ohara, Makoto, Fukui, Tomoyasu, Hirano, Tsutomu, Yamagishi, Sho-ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369823/
https://www.ncbi.nlm.nih.gov/pubmed/32646003
http://dx.doi.org/10.3390/ijms21134811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369823/
https://www.ncbi.nlm.nih.gov/pubmed/32646003
http://dx.doi.org/10.3390/ijms21134811

Ejemplares similares